The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice
Authors:
Open Access
- 5 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3512
Abstract
Given brucellosis is a widespread zoonosis in the world, a safe and effective vaccine is urgently needed. Recent trend in vaccine design has shifted to epitope-based vaccines that are safe and specific. In this study, peptide containing both T-cell and B-cell epitopes of OMP31 was synthesized and used to immunize the mice by nasal administration. The protective efficacy was evaluated. Mice immunized with the B epitope or TB epitope peptides of OMP31 had higher levels of IgG1 and IgG2a in the serum. While the BALB/c mice immunized with peptides containing T cell epitope or TB epitope of OMP31 showed high degree of IFN-γ-producing T cells in the lymphocytes from the respiratory draining lymph nodes and spleen. After intranasally challenged with 5 × 105CFU ofBrucella melitensis(strain 16 M), the bacterial loads in lung of the immunized mice were significantly lower than control group. These data demonstrate for the first time that peptides of OMP31 containing T epitope, B epitope or TB epitopes are of high immunogenicity and thus can protect host fromBrucella melitensisinfection in lung.Keywords
This publication has 39 references indexed in Scilit:
- Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimenMolecular Immunology, 2015
- Pathogenesis and Immunobiology of BrucellosisThe American Journal of Pathology, 2015
- Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of Brucella melitensis in miceResearch in Veterinary Science, 2015
- Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c miceMolecular Immunology, 2015
- 5-Lipoxygenase Negatively Regulates Th1 Response during Brucella abortus Infection in MiceInfection and Immunity, 2015
- Evaluation of the Efficacy of Outer Membrane Protein 31 Vaccine Formulations for Protection against Brucella canis in BALB/c MiceClinical and Vaccine Immunology, 2014
- Humoral Immunity and CD4+ Th1 Cells Are Both Necessary for a Fully Protective Immune Response upon Secondary Infection with Brucella melitensisThe Journal of Immunology, 2014
- The vaccine candidate BLSOmp31 protects mice against Brucella canis infectionVaccine, 2013
- Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st centuryPreventive Veterinary Medicine, 2011
- Intranasal Vaccination with the Recombinant Listeria monocytogenes ΔactA prfA*Mutant Elicits Robust Systemic and Pulmonary Cellular Responses and Secretory Mucosal IgAClinical and Vaccine Immunology, 2011